1. Understand the rationale for choosing one agent over the other
2. Discuss patient and disease related factors in care planning to optimize outcomes
3. Discuss current challenges and issues in acute lymphoblastic leukemia
Monday, May 03, 2021 6:00 PM EST
Dr. Lynn Savoie
This program was made possible through sponsorship support from Amgen.
ABOUT THE SPEAKERS
Bio Coming Soon!
Dr. Lynn Savoie is a Clinical Associate Professor in the Departments of Medicine and Oncology at the University of Calgary as well as a member of the Department of Hematologic Malignancies and Bone Marrow Transplantation at the Tom Baker Cancer Centre in Calgary. She received her medical degree from Dalhousie University in Halifax where she also completed her internal medicine residency. Her hematology fellowship was completed at the University of Manitoba followed by a clinical Leukemia/Bone marrow transplantation fellowship with the Leukemia/BMT program of British Columbia.
Her interests lie in myeloid malignancies and medical education. She is the local primary investigator for a number of clinical trials including in CML and AML. For the past several years she has been the chair of the hematology component of medical education at the University of Calgary. She is also actively involved in Physician evaluation as an examiner for the Royal College of Physicians and Surgeons of Canada in Internal Medicine as well as the chair of the Hematology exam committee.
Questions can be directed to firstname.lastname@example.org.